Capital Building in Washington DC

Advocacy & Policy

To improve patient care, ASCO advocates for increased federal funding for research, greater health care access, value in cancer care, and payment reform.

  • CDC Clarifies Opioid Prescribing Guideline

    The Centers for Disease Control and Prevention (CDC) recently issued a letter clarifying its Guideline for Prescribing Opioids for Chronic Pain at the urging of ASCO, the American Society of Hematology, and the National Comprehensive Cancer Network.

    Read More
  • ASCO Urges HHS to Eliminate Protection for Manufacturer Rebates

    ASCO recently submitted comments to the Department of Health and Human Services (HHS) in response to a proposed rule that would eliminate protection for manufacturer rebates on prescription drugs in the Medicare and Medicaid programs.

    Learn More
  • New Federal Bill Would Curb E-Cigarette Use Among Adolescents

    ASCO has endorsed the Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction (PROTECT) Act, which would authorize $100 million in funding each year for 5 years for a Centers for Disease Control and Prevention initiative to address the alarming rise in use of e-cigarettes by adolescents.

    Read More

Random Quote

"As medical professionals and as a Society, we must all continue to evolve and transform cancer care and research with each new discovery."
Julie M. Vose, MD, MBA, FASCO
ASCO President, 2015-16